Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER_GOV 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 1870Neoplasms 1254Colorectal Neoplasms 1057Carcinoma, Non-Small-Cell Lung 1012Stomach Neoplasms 801Carcinoma, Hepatocellular 784Lung Neoplasms 768Prostatic Neoplasms 697Pancreatic Neoplasms 578Rectal Neoplasms 447Ovarian Neoplasms 406Colonic Neoplasms 405Uterine Cervical Neoplasms 400Neoplasm Metastasis 400Recurrence 380Leukemia, Myeloid, Acute 372Esophageal Neoplasms 363Multiple Myeloma 339Lymphoma 335Head and Neck Neoplasms 329Melanoma 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Brain Neoplasms 263Urinary Bladder Neoplasms 254Liver Neoplasms 225Nasopharyngeal Carcinoma 223Leukemia 218Lymphoma, Large B-Cell, Diffuse 215Polycystic Ovary Syndrome 210Squamous Cell Carcinoma of Head and Neck 204

Interventions

Decitabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Hematopoietic System--Cancer × Clear all
NCT03687463 2018-10-02

Modified Post-Transplant Cyclophosphamide Regimen for Children With Juvenile Myelomonocytic Leukemia

Capital Research Institute of Pediatrics

Unknown
6 enrolled

Hematopoietic System--Cancer

NCT03654703 2018-08-31

Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML

Capital Research Institute of Pediatrics

Phase 2 Unknown
100 enrolled

Hematopoietic System--Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡